• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

CBER Participation in CBER Liaison and Roundtable Meetings with Industry

Description: CBER holds recurring liaison and roundtable meetings with outside organization to provide an opportunity to discuss topics of mutual interest and for outside concerns to be expressed, as well as to provide information on CBER’s operations. OCOD serves in a coordinating role by scheduling and documenting liaison and roundtable meetings with industry, trade associations and consumer organizations. This key project will be to evaluate these meetings and determine what, if any, changes need to be made to the program.

Briefing Status: DELAYED

Prior Briefing Status: DELAYED

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date

A. Contact CBER Program Offices to identify the organizations for liaison and roundtable meetings each plans to support during the calendar year.

2/15/2012

Completed 1/15/2012

B. Develop survey to solicit feedback from CBER Program Offices regarding the liaison/roundtable meeting program.

9/15/2012

Completed 9/15/2012

C. Processing of liaison meeting requests: Capture the number of internal pre-meetings and external liaison/roundtable meetings scheduled during the quarters: 4/5/2012 (1), 7/5/2012, 10/5/2012, and 1/5/2013

1/5/2013

Completed 1/30/2013

D. Upon completion of liaison/roundtable meetings for the calendar year, administer survey to CBER Program Offices regarding resources spent, time, value of meeting discussions.

1/15/2013

Completed 6/14/2013

E. Evaluate survey results and prepare report for CBER Office Directors with recommendations for potential changes to program (2).

3/1/2013

Delayed

F. Program or SOPP revisions based on evaluations results (2).

5/1/2013

Delayed

Footnotes

  • (1) There have been 3 internal pre-meetings and 0 external liaison/roundtable meetings during the first quarter of calendar year 2012.
  • (2) The dates for milestones E and F were adjusted as the due date for milestone D was missed.The milestone status reflects the current reporting quarter’s status. If a milestone is missed, the milestone will remain delayed until the milestone is completed.

Key Projects Legend

Milestone StatusDefinition
Not Yet StartedWork for specific milestone has not yet been started.
CompletedMilestone and/or overall project is completed.
On TrackMilestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status.
On HoldMilestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status.
DelayedMilestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status.

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.